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Background: Previous studies suggest patients with co-occurring alcohol use disorders (AUDs) 
and severe mental health symptoms (SMHS) are less satisfied with standard AUD treatment 
when compared to patients with an AUD alone. This study compared patient satisfaction with 
standard AUD treatment among patients with and without SMHS and explored how standard 
treatment might be improved to better address the needs of these patients.
Methods: Eighty-nine patients receiving treatment for an AUD either at an inpatient hospital, 
outpatient clinic, inpatient detoxification, or residential/therapeutic community services were sur-
veyed. Patient satisfaction with treatment was assessed using the Treatment Perception Question-
naire (range: 0–40). Patients were stratified according to their score on the Depression Anxiety 
Stress Scale. Forty patients scored in the extremely severe range of depression (score 14) and/
or anxiety (score 10) (indicating SMHS) and 49 patients did not. An inductive content analysis 
was also conducted on qualitative data relating to areas of service improvement.
Results: Patients with SMHS were found to be equally satisfied with treatment (mean =25.10, 
standard deviation =8.12) as patients with an AUD alone (mean =25.43, standard deviation =6.91). 
Analysis revealed that being an inpatient in hospital was associated with reduced treatment satisfac-
tion. Patients with SMHS were found to be significantly less satisfied with staffs’ understanding of 
the type of help they wanted in treatment, when compared to patients with AUDs alone. Five areas 
for service improvement were identified, including staff qualities, informed care, treatment access 
and continuity, issues relating to inpatient stay, and addressing patients’ mental health needs.
Conclusion: While findings suggest that AUD treatment services adequately meet the needs 
of patients with SMHS in treatment, patients with SMHS do feel that staff lack understanding 
of their treatment needs. Findings have important implications as to how current health care 
practice might be improved according to the patient’s perspective of care.
Keywords: MeSH, alcohol use disorder, treatment, mental disorder, comorbidity, patient 
satisfaction
Introduction
Patient compliance and dropout are considered significant challenges in the treatment 
of addiction. Previous studies report that only 28% of persons with addictions seek 
treatment in a given year,1 and of those, the proportion of patients who drop out of 
treatment ranges from 36% and 44% across addiction services.2 Patient satisfaction 
with treatment refers to the degree to which patients perceive the treatment service and 
staff have addressed their individual wants and needs.3 Patient satisfaction with treat-
ment is recognized as a particularly important construct in the treatment of addictions,4 
due to its close link to patient adherence and compliance. Researchers propose that 
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patients who are satisfied with treatment are more likely to 
continue treatment, enabling treatment to be more effective.5 
Patient satisfaction has been linked to positive outcomes of 
addiction treatment, including longer retention in inpatient 
services,6 increased variation of services utilized in outpatient 
settings,7 increased use of aftercare programs,8,9 and reduced 
alcohol intake.5
Among patients who seek treatment for an alcohol use dis-
order (AUD), 33%–55% present with additional depression 
and/or anxiety symptoms that require clinical intervention.10,11 
Patients with co-occurring severe mental health symptoms 
(SMHS) are a particularly vulnerable group in standard 
AUD treatment.12 Compared to patients with a single AUD, 
patients with SMHS are less likely to engage, retain, and 
respond to treatment.13,14 Accordingly, patients with SMHS 
are at risk of poorer treatment outcomes such as increased 
risk of disability,15 suicidality,16 psychopathology, and over-
all poorer quality of life. Furthermore, patients with SMHS 
strain treatment services through high service utilization 
and costs.17,18
In standard AUD treatment, a proportion of patients 
present with symptoms of depression and/or anxiety, which 
fall short of meeting full diagnostic criteria;12 but nonethe-
less negatively affect the patient’s functioning and treat-
ment outcomes.19 Researchers have argued that diagnostic 
assessments lack sensitivity and rather recommend the use of 
measures of mental health symptoms.20 While a proportion of 
patients will experience a decline in symptoms of anxiety and 
depression after detoxification without clinical intervention, 
a proportion will continue to experience symptoms posttreat-
ment, placing them at an increased risk of relapse.21
Patients with SMHS present to treatment with complex 
needs12 that are often not fully addressed by standard AUD 
treatment.14,22 As a result, there is a common understand-
ing in the literature that patients with SMHS report poorer 
satisfaction with standard AUD treatment when compared to 
patients with a single AUD.4 We have identified, however, 
only two studies that directly compared patient satisfaction 
among those with co-occurring mood disorders and AUDs 
to patients with a single AUD, within an addiction treatment 
setting.11,14 A 2009 prospective study (n=2,496) found that 
patients with both mood disorders and AUDs were sig-
nificantly less satisfied with treatment, compared to patients 
with a single AUD.14 However, a prospective study (n=71) 
reported no differences between groups in the same setting.11 
Another prospective study (n=92) reported no significant 
differences in satisfaction among patients with and without 
co-occurring diagnoses, in a psychiatric setting.22 It should 
be noted that these studies identified involved samples where 
patients met diagnostic criteria for both disorders, possibly 
limiting their interpretability in relation to patients with 
SMHS. A 2011 systematic review of 27 studies investigated 
patient satisfaction with treatment among patients with co-
occurring mental disorders and substance use diagnoses. The 
authors reported that studies have yet to control potential 
confounding variables that have been linked to patient sat-
isfaction for single diagnoses samples,4 including treatment 
setting23 and patient treatment readiness.4
A previous study suggests that patients with an external 
locus of health control toward the course of their AUD 
are less motivated for treatment24 and consequently may 
be less satisfied. At the same time, those patients with an 
internal locus of control more readily accept and participate 
in treatment.25 Patient appraisals of treatment are formed 
based on cognitive judgmental processes.26 It is, therefore, 
important to consider patients’ general cognitive judgments 
to ensure that their appraisals of treatment are a true reflec-
tion of their actual treatment experiences. Research has 
yet to consider the role of these variables in the assessment 
of patient satisfaction with treatment.
This study aimed to compare patient satisfaction with 
standard AUD treatment among patients with and without 
SMHS. Patient satisfaction with treatment was assessed 
according to the Treatment Perception Questionnaire (TPQ), 
which assesses patients’ perceptions of both the treatment 
service/program and staff. On the basis of previous research, 
we hypothesized that patients with SMHS would be less 
satisfied with standard treatment when compared to patients 
with a single AUD. This study was designed to control for the 
potential impact of treatment setting, treatment readiness, locus 
of health control, and life satisfaction, on patient satisfaction 
with treatment. We hypothesized that, collectively, these 
variables would play a large role in patients’ assessments of 
treatment. A secondary aim of this study was to investigate 
whether patients with SMHS are less satisfied with certain 
aspects of treatment when compared to AUD patients without 
SMHS, and how areas of treatment might be improved from 
the patient perspective. To the authors’ knowledge, this is the 
first study to compare patient satisfaction with AUD treatment 
among patients with and without SMHS, while controlling for 
the impact of previously underresearched variables.
Methods
Design
This study used a cross-sectional design to compare patient 
satisfaction with standard AUD treatment among patients 
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with and without SMHS. Both quantitative and qualitative 
data were obtained from patients using a survey method-
ological approach.
setting
Patients were recruited from four services that operate 
under the same government-funded body in Adelaide, 
South Australia. These services offer standard AUD treat-
ment, including both pharmacological and/or psychological 
approaches specifically tailored toward reducing patients’ 
alcohol use. Services included an inpatient tertiary hospital 
service where patients received pharmacological treatment, 
assessments, and coordination of care for injuries or diseases 
related to alcohol (inpatient hospitalization). An outpatient 
service that operates within the same tertiary hospital was also 
included (outpatient). This service provides pharmacological 
treatment and general counseling support to patients and acts as 
a follow-up to inpatient stay. This study also recruited patients 
from an inpatient withdrawal management unit located within 
a specialist psychiatric hospital where substance withdrawal 
is monitored by medical staff (inpatient detoxification). At 
this service, patients’ withdrawal from alcohol is monitored 
for 5–7 days with medical, and pharmacological interventions 
(eg, benzodiazepines). Comprehensive assessments, discharge 
planning, and counseling are also offered. The final service 
was a residential therapeutic community where patients reside 
for a period of 3–12 months and receive counseling from staff 
and peers and engage in a structured program.
sample
Participants were required to meet Diagnostic and Statistical 
Manual criteria for an AUD, and alcohol had to be their main 
substance of concern. Participants were excluded if they did 
not attend their outpatient appointment, had consumed alcohol 
in the 5 days prior to intake to the study, or were under the 
age of 18 years. Patients were required to be abstinent from 
alcohol for at least 5 days to minimize the impact of alcohol 
withdrawal syndrome on patients’ reported anxiety symptoms. 
Participants were excluded if they were not cognitively able 
to participate or if treatment staff assessed the participant as 
too medically or psychologically unwell to participate.
Procedure
Ethical approval was obtained from Royal Adelaide Hospital 
Human Research Ethics Committee and University of 
Adelaide Human Research Ethics Committee. All procedures 
were conducted in accordance with the National Health 
and Medical Research Council ethical guidelines. Written 
informed consent was obtained from all participants prior 
to inclusion in the research study. Participant recruitment 
occurred at the tertiary hospital between September 2013 
and June 2014. Participants were recruited at the residential/
therapeutic community from November 2013 to February 
2014, and at the inpatient withdrawal unit from February 
2014 to April 2014. The primary investigator consulted with 
treatment staff to identify patients who might be eligible 
for the study (eg, alcohol main substance of concern, meet 
AUD criteria; n=170) (Figure 1). A total of 143 patients were 
visited, and the staff then conducted a prescreen to assess 
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Figure 1 Process of recruitment.
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if the participant was well enough to participate. A total of 
118 patients were invited to participate and were screened 
to assess AUD criteria and cognitive ability; ten participants 
were excluded for cognitive impairment. The questionnaire 
was given to 108 patients and was returned to the primary 
investigator. However, in some cases, participants wished 
to complete the questionnaire at a later time, and thus 19 
surveys were lost to follow-up. A total of 89 respondents 
returned completed surveys.
Measures
screening
AUD diagnoses were assessed according to the Mini Interna-
tional Neuropsychiatric Interview (MINI 6.0)27 for 12-month 
AUD Diagnostic and Statistical Manual of Mental Disorders, 
fourth edition (DSM-IV) criteria, as instruments for DSM-5 
criteria were not available at the time of study design. An 
additional question was added to the screening instrument 
to incorporate the added craving criterion in the DSM-5.28 
Patient cognitive functioning was assessed using the MINI 
Mental State Examination.29
Questionnaire
Patients provided demographic information and clinical 
characteristics using the Addiction Severity Index-Self 
Report (ASI-SR).30,31 The ASI-SR assesses seven areas of 
functioning affected by addiction: employment, medical, 
psychiatric, familial/social, alcohol, drug, and legal. A com-
posite score for each area is produced (0–1), where higher 
scores represent more severe problems with functioning.32 
Internal consistency of the ASI ranges from moderate to high 
(0.70 and higher).33
Patient satisfaction with treatment (outcome 
variable)
Patient satisfaction with treatment was assessed using the 
TPQ.3 The TPQ includes ten Likert scale items; five items 
are negatively worded to reduce acquiescence bias. The TPQ 
was developed in inpatient and community treatment samples 
for substance use disorders and methadone maintenance 
programs;3 it was chosen due to its validity, brevity, and 
ability to be applied in a variety of modalities of addiction 
treatment;3 and participants are required to respond to ten 
items using a 5-point Likert scale, ranging from strongly dis-
agree to strongly agree. The sum of all ten items is calculated 
to produce a global satisfaction score, ranging from 0 to 40. 
Higher scores represent increased satisfaction with treatment, 
while lower scores represent dissatisfaction with treatment. 
Assessments of internal consistency have revealed good- 
to-excellent correlations for the staff perception (0.58–0.86) 
and average-to-excellent correlations for program perception 
subscales (0.37–0.92).3 The TPQ also includes an open-
ended item where patients provide qualitative feedback and 
make recommendations for improvements to treatment.3 
The item is:
Please write down in the box below any comments you 
would like to give us about the treatment you have received 
here. We would be very interested if you could tell us how 
you think we could improve the service.
The qualitative analysis of the open-ended TPQ response 
was added to the overall quantitative analysis using compli-
mentary techniques.34 This process is where different data 
sources offer complementary information on the one issue, 
which can be combined to examine different aspects of a 
research question.34
confounding variables
Treatment readiness was assessed using the Readiness to 
Change Questionnaire-Treatment Version (RTCQ-TV).35,36 
The RTCQ-TV assessed participants’ stage of thinking toward 
changing their AUD course, according to the stage of change 
theory.37 Assessments of internal consistency indicate a mod-
erate correlation for the precontemplation scale (0.34–0.51), 
adequate correlation for the contemplation scale (0.30–0.40), 
and good correlation for the action scale (0.32–0.67).35 Locus 
of health control was assessed using the Multidimensional 
Health Locus of Control (MHLC)38,39 questionnaire (Form C). 
Participant responses were allocated to two subscales: internal 
or external. Assessments of internal consistency indicate good 
correlations for internal (0.85–0.87), chance (0.79–0.82), 
doctors (0.71), and other people (0.70–0.71) subscales.40 
Life satisfaction was assessed using the Satisfaction with 
Life Scale (SWLS),26 which produced an overall satisfaction 
score, ranging from 5 to 35. The SWLS is considered a highly 
validated and reliable measure of satisfaction, which can be 
applied in a wide range of groups and samples.41
Patient mental health symptoms (predictor variable)
Patient mental health symptoms were assessed using the 
Depression Anxiety Stress Scale (DASS-21) (range: 0–21).42 
Respondents were asked how much items applied to them 
within the previous 7 days. However, if participants had 
undergone alcohol withdrawal in the 7 days prior, they were 
asked to respond according to how they felt since withdrawal 
symptoms have subsided. Participants who scored in the 
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“extremely severe” range of the depression (DASS-21 score 
of 14 and above) and/or anxiety (DASS-21 score of 10 and 
above) subscales were grouped as patients with SMHS. This 
cutoff was used as symptoms within this range are considered 
clinically significant and require intervention and treatment.42 
Patients scoring in remaining categories were allocated to the 
“single AUD group”. Measures of internal consistency for 
the DASS-21 in a clinical population have reported good-
to-excellent coefficients for the depression (0.96), anxiety 
(0.89), and stress (0.93) subscales.43
Data analysis
Power analysis indicated that 80 cases (n=40 with and n=40 
without SMHS) were required to conduct univariate com-
parisons between the groups, based on a mean difference of 
5 points on the TPQ and at the 5% α level with a power of 
87%. Multiple regression analysis was based on a require-
ment of ten cases per predictor.44 The sample of 80 patients 
was considered adequate to account for the five predictors 
intended to enter the analysis. It was anticipated that data 
may be missing in 10% of cases; therefore, the total number 
of completed surveys required for this study was increased 
to 88. Patient recruitment ceased after the author had obtained 
at least 88 completed surveys.
Independent samples t-tests and chi-square (χ2) analyses 
were conducted to compare groups on the variables of interest. 
A hierarchical multiple regression was conducted to determine 
if patient mental symptoms predicted a significant amount of 
variance in patient satisfaction, when controlling for the 
impact of confounding variables. Multicollinearity between 
the variables “outpatient” and “inpatient hospitalization” was 
identified; accordingly, two models were created in the regres-
sion analysis. All categorical predictor variables were dummy 
coded, and treatment setting (Model 1: inpatient hospital-
ization, outpatient, and residential therapeutic community; 
Model 2: inpatient hospitalization, outpatient, and inpatient 
detoxification), treatment readiness (0= contemplation, 1= 
action), locus of health control (0= internal, 1= external), and 
life satisfaction were entered into the model at Step 1. Patient 
mental symptoms were entered at Step 2.
This study also aimed to determine if patients with SMHS 
were significantly more dissatisfied with specific aspects of 
treatment, when compared to patients without SMHS. To test 
this question, all items of the TPQ satisfaction instrument 
were recoded into new variables. Responses of 0 “strongly 
disagree” were recoded as 1 and all remaining responses were 
recoded as 0. We chose to focus only on “strongly disagree” 
responses to detect areas of positive dissatisfaction and thus 
identify aspects that may benefit from review. χ2 tests for 
independence (with Fisher’s exact test) were conducted for 
each item of the TPQ. In the presentation of results, negatively 
worded items were reworded to maintain consistency.
An inductive content analysis was conducted on quali-
tative data produced from the open-ended question of the 
TPQ on service improvement. The basic inductive content 
analysis approach aims to reduce qualitative text into related 
codes and themes45 and is commonly used to reduce text 
from open-ended survey questions.46 The inductive content 
analysis approach involved three main stages: open coding, 
grouping the data, and abstraction.47 Codes were generated 
by rereading the text and allocating appropriate headings, 
codes, and themes to the data. Codes were grouped accord-
ing to positive comments/satisfaction or negative comments/
dissatisfaction, and subsequently coded as to whether data 
related to treatment staff or the treatment service. The final 
stage involved abstraction of the data, where main categories 
were formulated based on the grouping of headings of codes 
according to similarities and shared ideas.47
Results
Demographic, clinical, and treatment-
related characteristics
A total of 89 completed surveys were included in analysis 
(response rate of 82%). The sample comprised 67% men 
and 33% women, with a mean age of 48.32 years (Table 1). 
Patients with SMHS reported significantly higher symptoms 
of depression (M =14.13, SD =4.40 vs M =5.55, SD =4.03), 
anxiety (M =13.10, SD =4.18 vs M =3.04, SD =2.80), 
stress (M =14.45, SD =3.76 vs M =5.59, SD =3.55), and 
overall higher psychiatric severity (M =0.51, SD =0.21 vs 
M =0.31, SD =0.21) compared to patients with single AUDs. 
Patients with SMHS also reported more significant difficul-
ties in areas of medical (M =0.49, SD =0.38 vs M =0.33, 
SD =0.34), familial/social (M =0.40, SD =0.23 vs M =0.28, 
SD =0.27), and alcohol severity (M =0.62, SD =0.32 vs 
M =0.47, SD =0.29). Patients with SMHS were significantly 
less satisfied with life compared to patients with single AUD 
(M =12.97, SD =6.85 vs M =16.82, SD =8.20). No differences 
were observed between groups on treatment readiness, locus 
of health control, and satisfaction with treatment (M =25.10, 
SD =8.12 vs M =25.43, SD =6.91).
impact of sMhs on patient satisfaction 
with treatment
Table 2 lists the impact of patient mental symptoms on sat-
isfaction with treatment while accounting for confounding 
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variables: treatment modality, treatment readiness, health 
locus of control, and satisfaction with life. Confounding 
variables explained only 12.8% of the total variance in 
patient satisfaction with treatment. After entry of patient 
mental symptoms, the total variance explained by the model 
was 12.9% and was not significant (P=0.75). Patient mental 
symptoms explained only 0.1% of the variance in patient 
satisfaction, after accounting for the confounding variables 
(P=0.75). In the final model, only the inpatient hospitaliza-
tion variable remained statistically significant (P=0.03). 
Receiving treatment as an inpatient in hospital, as opposed to 
the outpatient or residential/therapeutic community setting, 
was associated with a 4.45-point decrease on the measure of 
patient satisfaction with treatment.
comparing satisfaction with treatment 
among patients with and without sMhs
Patients with SMHS were significantly more likely to 
“strongly disagree” with the statement “the staff have 
understood the kind of help I want” compared to patients 
without SMHS (P=0.02; Table 3). No other differences 
were observed between the two groups. Twenty percent of 
patients with SMHS were dissatisfied with treatment rules 
and regulations; however, this was not statistically different 
to patients with an AUD alone (12.2%). Similarly, patients 
with SMHS were more dissatisfied with the statement “staff 
and I have similar ideas about what my treatment objectives 
should be” (7.5% vs 0%); however, this was not statistically 
significant between the groups.
Open-ended responses about 
improvements to services
Of the 89 completed surveys, 51 (57%) included a response 
to the open-ended question about how services might be 
improved to better accommodate patient needs. As quanti-
tative data indicated little differences between groups, we 
explored results of the open-ended survey question across 
the total sample. Twenty-one (41%) of the responses were 
positive appraisals of staff and treatment. Thirty responses 
(59%) were comments relating to patient dissatisfaction or 
areas for improvement. Content analysis of the responses 
provided by patients detected five areas of treatment that 
patients believed could be improved.
staff qualities
Patients explained that it was important for all service staff to 
be sufficiently trained in addiction, to understand the nature 
of their condition and provide best treatment practice:
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Staff need to be more sympathetic and listen carefully to the 
mental states of patients. There is no one formula to fix every 
patient in the same way, there is no average alcoholic. [25 year 
old male with SMHS; inpatient detoxification service].
Keeping the patient informed
Patients expressed a desire to be better informed about what 
to expect during treatment. Patients wished to be regularly 
informed of the medications they were given, reasoning for 
changing doses, results of monitoring, ie, blood pressure, 
and better explanation of what happens to the body through 
withdrawal.
Treatment access and continuity
Many patients described difficulties with accessing treatment, 
including lack of treatment services available, long waiting 
periods for services, and the cost of medications. Patients 
also described dissatisfaction with the coordination between 
services and were concerned about what treatment resources 
were available postdischarge.
Table 2 impact of mental health symptoms on patient satisfaction with treatment, while accounting for the impact of treatment setting, 
treatment readiness, locus of health control, and satisfaction with life
Predictor B SE B β t P-value R2 R2 change
Model 1
step 1
inpatient hospitalization* -4.45 2.06 -0.27 -2.16 0.03
Outpatient -2.68 2.33 -0.15 -1.16 0.25
residential therapeutic community -4.29 2.46 -0.23 -1.74 0.08
Treatment readiness 2.23 1.80 0.15 1.24 0.22 0.128
health locus of control -1.64 1.66 -0.11 -0.99 0.33
satisfaction with life 0.17 0.12 0.18 1.44 0.15
step 2
Mental symptoms 0.55 1.73 0.04 0.31 0.75 0.129 0.001‡
Model 2
step 1
inpatient hospitalization -0.16 2.66 -0.01 -0.06 0.95
Outpatient clinic 1.61 2.84 0.09 0.57 0.57
Inpatient detoxification 4.29 2.46 0.27 1.74 0.09
Treatment readiness 2.23 1.80 0.15 1.24 0.22
health locus of control -1.64 1.66 -0.11 -0.99 0.33 0.128
satisfaction with life 0.17 0.12 0.18 1.44 0.15
step 2
Mental health symptoms 0.55 0.73 0.04 0.31 0.75 0.129 0.001‡
Notes: Unstandardized regression coefficients (B), unstandardized regression coefficients standard error (SE B), standardized regression coefficients (β), t-values (t), P-values (P), 
R square values (R2), and R square change (R2 change), *P0.05; ‡F (7.81) =1.71, P0.05, R2 change =0.001, F change (1.81) =0.099. Values in bold indicate statistically significant 
data.
Table 3 Percentage of patients in the sample who responded strongly disagree to each item of the Treatment Perception Questionnaire 
(TPQ)
TPQ item Patients with coexisting  
AUD and SMHS (n=40)
Patients with AUD 
only (n=49)
(a) The staff have understood the kind of help i want* 17.5%* 2.0%*
(b) i have been well informed about decisions made about my treatment 5.0% 4.1%
(c) The staff and i have had similar ideas about what my treatment objectives should be 7.5% 0.0%
(d) There has always been a member of staff available when i have wanted to talk 10.0% 10.2%
(e) The staff have helped to motivate me to sort out my problems 10.0% 8.2%
(f) i have liked the treatment sessions i have attended 7.5% 4.1%
(g) i have had enough time to sort out my problems 10.0% 4.1%
(h) i think the staff have been good at their jobs 2.5% 8.2%
(i) i have received the help that i was looking for 5.0% 10.2%
(j) i have liked most of the treatment rules or regulations 20.0% 12.2%
Notes: *P0.05. Table adapted from Marsden J, stewart D, gossop M, et al. Assessing client satisfaction with Treatment for substance Use Problems and the 
Development of the Treatment Perceptions Questionnaire (TPQ). Addiction Research. 2000;8(5):455–470. reprinted by permission of the publisher (Taylor & Francis ltd, 
www.tandfonline.com).3
Abbreviations: AUD, alcohol use disorder; sMhs, severe mental health symptoms. 
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issues relating to inpatient stay
Patient dissatisfaction with treatment was often related to issues 
of inpatient stay. Issues included being bored, a lack of privacy 
with shared rooms, feeling scared, and personality clashes with 
other inpatients. Patients in the inpatient detoxification service 
suggested that outdoor program activities would reduce their 
stress in treatment, eg, vegetable garden, animal visits, outdoor 
painting, outdoor exercise, and smoking areas.
Mental health treatment needs
Patients expressed a desire for treatment to focus more on 
their mental health symptoms. Patients suggested assess-
ments of mental health, improved mental treatment plans, 
and increased one-on-one access to a full-time drug and 
alcohol counselor:
Some counseling and mental treatment plans need to be 
more systematic in their approach, at times I have felt mis-
managed or unmanaged, no overarching plan in existence.
[37 year old male with SMHS; inpatient detoxification 
service].
Discussion
Studies to date have yet to control for potential confounding 
variables that have been linked to patient satisfaction for single 
diagnosis samples.4 Thus, this is the first study to account for 
the impact of treatment setting, treatment readiness, locus of 
health control, and life satisfaction, when comparing patient 
satisfaction with standard AUD treatment, among patients 
with and without SMHS. This study was strengthened by 
specific assessment of the most common symptoms of mental 
illness in AUD patient groups, at the time of treatment. Other 
strengths of this study include the incorporation of various 
treatment settings and comprehensive assessment of patient 
mental symptoms. Previous studies report that SMHS often 
go undetected and untreated in addiction treatment settings, 
despite widespread recognition of the negative impact they 
have on patient outcomes.13,19
Results suggest that patients in this sample were, on 
average, satisfied with the treatment they received. In fact, 
patients with SMHS reported higher treatment satisfaction 
scores than treatment samples with co-occurring diagnoses 
in the UK,48–50 according to the same satisfaction measure. 
Similarly, the single AUD patient group reported higher sat-
isfaction scores than single substance use disorder treatment 
samples in Scotland,23 Spain,51 and inpatients in England;52 
comparable satisfaction scores to patients in Italy;51 and 
reduced satisfaction compared to patients in Portugal51 and 
outpatients in England,52 using the same satisfaction mea-
sure. However, the diagnostic characteristics of the samples 
included in these studies were dissimilar to the current study, 
limiting meaningful cross-comparison of satisfaction data. 
Contrary to our predictions, results indicate that patients 
with SMHS were equally satisfied with treatment as patients 
with single AUD, even after accounting for confounding 
variables. This result supports previous findings reported 
by two small-scale studies11,22 and adds further evidence that 
standard treatment may indeed address the needs of patients 
with SMHS.4 Results also suggest that factors such as treat-
ment readiness, health locus of control, and satisfaction with 
life had minimal impact on satisfaction with treatment for 
patients in this sample. It is often thought that patients who 
report negative experiences of treatment are likely to lack 
motivation,4 lack a personal responsibility for change,24,25 
or might be inclined to negatively appraise experiences;26 
however, the results obtained from this study do not support 
this. The only variable to significantly impact on patient 
satisfaction with treatment was inpatient hospitalization. 
This result might suggest that patient needs may be bet-
ter addressed in other settings and supports results from a 
similar study that found that inpatients were significantly 
less satisfied with opioid substitution treatment when com-
pared to outpatients in the same treatment program.52 At the 
same time however, it is probable that inpatients are likely 
to report poorer experiences of treatment due to their more 
immediate and severe needs, rather than the setting itself. 
In fact, patients in the hospital in this study were more likely 
to report SMHS compared to other settings, with SMHS 
being associated with higher medical, familial/social, and 
alcohol severity.
On the whole, quantitative analyses revealed minimal dif-
ferences between the groups in respect to patient satisfaction 
with treatment. However, a major finding was that patients 
with SMHS were more dissatisfied with staff understanding 
of the type of help they wanted in treatment (17.5% vs 2%). 
The importance patients place on their relationship with 
staff is well documented in the literature,53,54 particularly 
staff skills in empathizing with patient needs.55,56 This was 
reflected by the qualitative content analysis findings, where 
patients indicated staff qualities as an area for improvement. 
In addition, quantitative findings might suggest that patients 
with co-occurring SMHS want existing treatments to rec-
ognize their psychological symptoms and accommodate 
suitable interventions to address symptoms. Although differ-
ences were statistically nonsignificant, patients with SMHS 
were more dissatisfied with the statement “staff and I have 
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similar ideas about what my treatment objectives should 
be” (7.5% vs 0%) and “I have liked most of the treatment 
rules and regulations” (20% vs 12.2%) than those without 
SMHS. This may reflect the qualitative findings, where 
patients with SMHS discussed their desire for treatment to 
address their mental health symptom needs. Patients also 
indicated that improvements could be achieved by managing 
patient expectations through informative communication, 
improving treatment access and patient linkage through 
services, addressing issues of inpatient stay, and placing 
more emphasis on patients’ mental symptoms.
This study contained several limitations. First, patient 
satisfaction with treatment was assessed at one time point, 
and time-in-treatment was also not controlled for. Satisfac-
tion is recognized as a dynamic construct and it is likely 
that patients’ satisfaction would have changed throughout 
treatment.57 Patients were required to attend their outpatient 
appointment or be engaged in treatment for at least 5 days, 
consequently 15% of patients meeting inclusion criteria were 
not approached for participation. It is likely that patients 
who did not attend their appointment or who prematurely 
discharged themselves from treatment might have been dis-
satisfied. Therefore, this study’s sample may have contained a 
higher concentration of satisfied patients and may not be a true 
representation of the views of all patients in treatment. Future 
studies should aim to assess satisfaction throughout treatment 
and attempt to track and assess the views of patients who do 
not attend or prematurely discharge themselves from treat-
ment. Another limitation of this study was that patient groups 
were stratified according to symptoms of mental illness, rather 
than standardized diagnostic assessments. Similarly, it is 
likely that the validity of the TPQ measure was reduced in the 
χ2 data analyses, as responses were recoded from continuous 
to dichotomous responses. There exists some research indi-
cating the limitedness of the Mini Mental State Examination 
in detecting cognitive impairment for patients with AUD, 
due to the absence of its ceiling effects and items assessing 
executive functioning, which are areas commonly affected 
by alcohol.58 However, one study suggests the Mini Mental 
State Examination is a suitable screening tool for research 
containing patients with AUDs,34 and it is routinely employed 
in current clinical practice. Finally, this study only assessed 
patients’ explicit attitudes through self-reported assessment 
of patients’ perceptions of treatment. Studies argue that mea-
sures of automatic, implicit attitudes provide superior predic-
tive power in comparison to measures of explicit attitudes.59 
It is possible that including measures of implicit attitudes in 
this study may have yielded different results.
This study’s findings have important implications for 
health care delivery and health care decision making with 
regard to improving treatment for patients with SMHS, 
based on the patients’ perception of care. First, findings 
present a positive result for local AUD services and should 
instill confidence in clinicians’ abilities to address the needs 
of patients both with and without SMHS. To improve the 
patient experiences of treatment, staff should feel confident 
in their ability to listen, understand, and respond to the type of 
help patients want and need in treatment. To improve patient 
experiences of treatment, service directors and policy makers 
are encouraged to consider the areas nominated by patients 
for review. Patients indicated that gains could be made by 
recognizing the importance of staff selection and training, 
more active management of patient expectations, handling 
confrontations among inpatients, and acknowledging patient 
mental symptoms. Similarly, service directors are encouraged 
to focus on improving the activities and opportunities avail-
able to inpatients in detox and address any issues patients 
might be experiencing in accessing and linking to services.
Conclusion
The complex needs of patients with coexisting AUDs and 
SMHS are often not fully addressed by standard AUD 
treatment, and thus might explain patients’ poorer treatment 
outcomes when compared to single AUD patients. However, 
this study found that patients with SMHS reported compara-
ble experiences of standard treatment to patients with AUDs 
alone, suggesting that their complex needs were adequately 
met during treatment. Further research is, therefore, required 
to better understand ways to improve outcomes for patients 
with coexisting mental health and alcohol-related symptoms 
after treatment.
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